Exploratory IND Studies: Guidance for Industry, Investigators, and Reviewers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 12, 2006
February 3, 2025
836b5809-de11-4db6-8f91-3671cf875e32
Related Documents
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
Recommended Approaches to Integration of Genetic Toxicology Study Results
Guidance DocumentJanuary 4, 2006Center for Drug Evaluation and Research
Prescription Drug Marketing Act — Donation of Prescription Drug Samples to Free Clinics
Guidance DocumentMarch 14, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox